Fig. 3From: Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon CarcinomaRelease study. DOX content leakage profile from Caelyx® and ED-lip at 37 °C at the presence of 50% FBS in dextrose during 24 h of study. Data represented as mean ± standard deviation (SEM) (n = 3)Back to article page